When traditional treatment failed, given just months to live, our founder became the first patient to enroll in an experimental CAR T cell clinical trial at UCLA.
A Remarkable Story of Survival
VOA Global Broadcast
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.